🕵️ Provectus Biopharmaceuticals, Inc. ($PVCT)
SEC insider & ownership activity, last 12 months · CIK 315545 · every row links its SEC filing
Over the last 12 months insiders bought $100K with no open-market selling against it. Pershing Edward bought $100K in discretionary trades (Feb). No red-flag 8-Ks in the window.
Insider flow
1 buyer, $100K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Pershing Edward | 1 | $100K | 0 | – | Feb 9, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pershing Edward | 11.6% | 13D | Jun 30, 2026 | filing ↗ | |
| Dominic Rodrigues | 5.7% | 13D | Dec 2, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |